[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Coccidioidomycosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 40 pages | ID: C72FA81889EDEN
VPAResearch

US$ 1,699.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Coccidioidomycosis Drug pipeline report- 2020 is an annual R&D review of Coccidioidomycosis pipeline candidates. The report presents the current status of all major Coccidioidomycosis therapeutic compounds. Detailed insights into Coccidioidomycosis pipeline development, current status, companies, drug profiles and Coccidioidomycosis preclinical and clinical trials are included.

2020 Coccidioidomycosis Pipeline Market Insights
Coccidioidomycosis disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Coccidioidomycosis therapies, pipeline by phase and others are included.

Coccidioidomycosis pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Coccidioidomycosis Therapeutic Drug candidates
Both active and inactive Coccidioidomycosis pipeline drug candidates are included in the report

Coccidioidomycosis Clinical Trials and preclinical Studies
Coccidioidomycosis In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Coccidioidomycosis pipeline market developments
Coccidioidomycosis Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Coccidioidomycosis pipeline companies in active development
The report analyzes Coccidioidomycosis pipeline of the below companies-

Acea Biotech Inc, Amplyx Pharmaceuticals Inc, F2G Ltd, Valley Fever Solutions Inc, Viamet Pharmaceuticals Inc

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
5 Companies investing in Coccidioidomycosis pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Coccidioidomycosis pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included
1. COCCIDIOIDOMYCOSIS PIPELINE MARKET INSIGHTS, 2020

1.1 Coccidioidomycosis Disease Overview
1.2 Coccidioidomycosis Drug Pipeline Snapshot, 2020
  1.2.1 Coccidioidomycosis Pipeline Drugs by Phase
  1.2.2 Coccidioidomycosis Pipeline Drugs by Company
  1.2.3 Coccidioidomycosis Pipeline Drugs by Mechanism of Action
  1.2.4 Coccidioidomycosis Pipeline Drugs by Route of Administration

2. COCCIDIOIDOMYCOSIS COMPANY WISE PIPELINE DETAILS

Acea Biotech Inc Coccidioidomycosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Amplyx Pharmaceuticals Inc Coccidioidomycosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
F2G Ltd Coccidioidomycosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Valley Fever Solutions Inc Coccidioidomycosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Viamet Pharmaceuticals Inc Coccidioidomycosis Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. COCCIDIOIDOMYCOSIS DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. COCCIDIOIDOMYCOSIS PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts


More Publications